Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Fortuna

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 9, 2010
Anesthetic activation of central respiratory chemoreceptor neurons involves inhibition of a THIK-1-like background K(+) currentRoman M Lazarenko, Michal G Fortuna, Yingtang Shi, et al.
European Journal of Medicinal Chemistry|June 24, 2019
Targeting COX-1 by mofezolac-based fluorescent probes for ovarian cancer detectionAntonio Scilimati, Savina Ferorelli, Maria Clara Iaselli, et al.
Molecular Therapy. Methods & Clinical Development|December 24, 2025
AAV-PHP.eB achieves superior neuronal transduction over AAV9 in pigtail macaques following intracerebroventricular administrationMichal G Fortuna, Lyle H Nyberg, Naz Taskin, et al.
European Journal of Medicinal Chemistry|October 17, 2017
Effect of mofezolac-galactose distance in conjugates targeting cyclooxygenase (COX)-1 and CNS GLUT-1 carrierMaria Grazia Perrone, Paola Vitale, Savina Ferorelli, et al.
European Journal of Medicinal Chemistry|July 16, 2017
Structural basis for selective inhibition of Cyclooxygenase-1 (COX-1) by diarylisoxazoles mofezolac and 3-(5-chlorofuran-2-yl)-5-methyl-4-phenylisoxazole (P6)Gino Cingolani, Andrea Panella, Maria Grazia Perrone, et al.
Clinical and Experimental Dermatology|February 24, 2018
Seven novel COL7A1 mutations identified in patients with recessive dystrophic epidermolysis bullosa from MexicoA H Saeidian, L Youssefian, M G Moreno Trevino, et al.
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Covalently Functionalized Halloysite-Calixarene Nanotubes for Injectable Hydrogels: A Multicavity Platform for Hydrophobic Drug DeliveryGiuseppe Cinà, Marina Massaro, Andrea Pappalardo, et al.
European Journal of Medicinal Chemistry|July 2, 2013
New linezolid-like 1,2,4-oxadiazoles active against Gram-positive multiresistant pathogensCosimo G Fortuna, Carmela Bonaccorso, Alessandra Bulbarelli, et al.
Pharmaceutics|November 27, 2024
Halloysite Nanotube-Based Delivery of Pyrazolo[3,4-<i>d</i>]pyrimidine Derivatives for Prostate and Bladder Cancer TreatmentMarina Massaro, Rebecca Ciani, Giancarlo Grossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervixS Pignata, G Silvestro, E Ferrari, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 9, 2010
Anesthetic activation of central respiratory chemoreceptor neurons involves inhibition of a THIK-1-like background K(+) currentRoman M Lazarenko, Michal G Fortuna, Yingtang Shi, et al.
European Journal of Medicinal Chemistry|June 24, 2019
Targeting COX-1 by mofezolac-based fluorescent probes for ovarian cancer detectionAntonio Scilimati, Savina Ferorelli, Maria Clara Iaselli, et al.
Molecular Therapy. Methods & Clinical Development|December 24, 2025
AAV-PHP.eB achieves superior neuronal transduction over AAV9 in pigtail macaques following intracerebroventricular administrationMichal G Fortuna, Lyle H Nyberg, Naz Taskin, et al.
European Journal of Medicinal Chemistry|October 17, 2017
Effect of mofezolac-galactose distance in conjugates targeting cyclooxygenase (COX)-1 and CNS GLUT-1 carrierMaria Grazia Perrone, Paola Vitale, Savina Ferorelli, et al.
European Journal of Medicinal Chemistry|July 16, 2017
Structural basis for selective inhibition of Cyclooxygenase-1 (COX-1) by diarylisoxazoles mofezolac and 3-(5-chlorofuran-2-yl)-5-methyl-4-phenylisoxazole (P6)Gino Cingolani, Andrea Panella, Maria Grazia Perrone, et al.
Clinical and Experimental Dermatology|February 24, 2018
Seven novel COL7A1 mutations identified in patients with recessive dystrophic epidermolysis bullosa from MexicoA H Saeidian, L Youssefian, M G Moreno Trevino, et al.
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Covalently Functionalized Halloysite-Calixarene Nanotubes for Injectable Hydrogels: A Multicavity Platform for Hydrophobic Drug DeliveryGiuseppe Cinà, Marina Massaro, Andrea Pappalardo, et al.
European Journal of Medicinal Chemistry|July 2, 2013
New linezolid-like 1,2,4-oxadiazoles active against Gram-positive multiresistant pathogensCosimo G Fortuna, Carmela Bonaccorso, Alessandra Bulbarelli, et al.
Pharmaceutics|November 27, 2024
Halloysite Nanotube-Based Delivery of Pyrazolo[3,4-<i>d</i>]pyrimidine Derivatives for Prostate and Bladder Cancer TreatmentMarina Massaro, Rebecca Ciani, Giancarlo Grossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervixS Pignata, G Silvestro, E Ferrari, et al.
Pageof 9